RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN) — all Canadian products
3 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02232478 | RESPIGAM | MEDIMMUNE LLC | Powder For Solution | Intravenous | RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 1000 MG | Cancelled Pre Market | |
| 02232479 | RESPIGAM | MEDIMMUNE LLC | Powder For Solution | Intravenous | RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 2500 MG | Cancelled Pre Market | |
| 02232480 | RESPIGAM | MEDIMMUNE LLC | Liquid | Intravenous | RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 50 MG | Cancelled Pre Market |
Browse other molecules: